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Abstract
Previous studies have demonstrated that the novel protein Gcp is essential for the viability of various bacterial species
including Staphylococcus aureus; however, the reason why it is required for bacterial growth remains unclear. In order to
explore the potential mechanisms of this essentiality, we performed RT-PCR analysis and revealed that the gcp gene
(sa1854) was co-transcribed with sa1855, yeaZ (sa1856) and sa1857 genes, indicating these genes are located in the same
operon. Furthermore, we demonstrated that Gcp interacts with YeaZ using a yeast two-hybrid (Y2H) system and in vitro pull
down assays. To characterize the Gcp-YeaZ interaction, we performed alanine scanning mutagenesis on the residues of C-
terminal segment of Gcp. We found that the mutations of the C-terminal Y317-F322 region abolished the interaction of Gcp
and YeaZ, and the mutations of the D324-N329 and S332-Y336 regions alleviated Gcp binding to YeaZ. More importantly,
we demonstrated that these key regions of Gcp are also necessary for the bacterial survival since these mutated Gcp could
not complement the depletion of endogenous Gcp. Taken together, our data suggest that the interaction of Gcp and YeaZ
may contribute to the essentiality of Gcp for S. aureus survival. Our findings provide new insights into the potential
mechanisms and biological functions of this novel essential protein.
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Introduction
The prevalence of methicillin-resistant Staphylococcus aureus
(MRSA) and vancomycin-resistant S. aureus (VRSA) has caused
serious public health concerns worldwide [1,2]. The limited
options of antibiotics for the treatment of infections associated with
MRSA and/or VRSA highlight an urgent need for the
development of novel potent antimicrobial agents. Bacterial
essential proteins are potential targets for the development of
new classes of antibiotics [3,4]; however, the biological function of
many essential proteins is still unclear. The characterization and
validation of functional unknown essential proteins are therefore of
great importance to assess their suitability as targets for the
development of the novel antibiotics.
Our previous studies have indicated that a novel essential
protein Gcp is a potential target for the development of new classes
of antibacterial agent against MRSA and/or VRSA [5,6]. Gcp is
homologous to the Gcp first identified in Mannheimia haemolytica
(formerly Pasteurella haemolytica) and specifically cleaves O-sialogly-
cosilated protein [7]. Gcp homologs are ubiquitous in all three
kingdoms of life, with the exception of the endosymbiotic bacteria
Carsonella ruddii and Sulcia muelleri, which possess highly reduced
genomes [8,9]; however, these Gcp homologs do not exhibit
glycoprotease activity. It has been revealed that these Gcp
homologs are required for cell viability of many bacterial species
examined to date, including S. aureus [10], Streptococcus pneumonia
[10], Escherichia coli [11], Bacillus subtilis [12,13], Francisella novicida
[14], Pseudomonas aeruginosa [15], and Mycoplasm genetalium [16].
Additionally, the protein is important for eukaryotes, such as
Saccharomyces cerevisiae [17] and Arabidopsis thaliana [18]. We have
demonstrated that S. aureus Gcp plays an important role in the
process of bacterial autolysis, suggesting a potential role in the cell
wall biosynthesis pathway [6], however, the reason why Gcp is
required for bacterial viability remains elusive.
Structural analysis of Gcp homologs shows that Gcp belongs to
the ASKHA (acetate and sugar kinases, HSP70 and actin)
superfamily [18–22]. A conserved metal binding motif HXEXH
is inserted within the HSP70 (heat-shock protein70)-actin-like fold
(HALF), suggesting a metal binding ability and an ATP dependent
protease activity [18]. The crystal structure analysis of the Gcp
Pyrococcus abyssi ortholog, Pa-Kae1, has revealed that Pa-Kae1is
multifunctional, binding iron and ATP, as well as possessing DNA
binding and apurinic endonuclease activity [20], whereas the Gcp
homolog in yeast, Kae1 (kinase -associated endopeptidase 1), is a
component of the KEOPS/EKC (kinase, endopeptidase and other
proteins of small size/endopeptidase-like and kinase associated to
transcribed chromatin) complex that are required for telomere
maintenance and transcription of essential eukaryotic genes
[21,23,24]. Collectively, the above data indicate that Gcp
homologs may possess different functions among different species.
Recently, it has been reported that in E. coli, an essential protein
YeaZ binds to YgjD (the Gcp homolog in E. coli) and YjeE, which
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specific member of the ASKHA superfamily. It is also essential for
growth of a variety of bacterial species [3,10–15], such as S. aureus
[10] and E. coli [11]. Crystal structural analyses reveal that the E.
coli [27], Samonella typhimurium and Thermotoga maritime YeaZs
possess a HALF fold, but lack the metal binding motif and the
ATP binding site [28,29]. This suggests that YeaZ may bind to a
nucleotide through an interaction with a small molecule ligand or
a partner protein to adopt an active conformation [28]. In
addition, EcYeaZ can specifically cleave YgjD [26], but StYeaZ
does not exhibit such an enzymatic activity [28].
Sequence alignment analysis revealed that S. aureus Gcp, YeaZ,
and SA1857 proteins are the homologs of YgjD, YeaZ, and YjeE
in E. coli, respectively [26], however, whether these proteins
interact with each other in S. aureus is currently unknown. In this
study, we utilized the genetic and biochemical approaches and
demonstrated that the staphylococcal Gcp binds to YeaZ.
Importantly, we have identified the key domains of Gcp that are
important for Gcp-YeaZ interaction, as well as critical for Gcp’s
essentiality for S. aureus growth.
Results
Both gcp and yeaZ genes are located in the same operon
Genomic DNA sequence alignment for S. aureus revealed that
the sequences of sa1857, yeaZ (sa1856), sa1855, and gcp (sa1854) are
sequentially overlapped (Fig. 1A). It was revealed that the first
47 bps of yeaZ overlap with the last 47 bps of sa1857; the first
28 bps of sa1855 overlap with the last 28 bps of yeaZ; and the first
8 bps of gcp overlap with the last 8 bps of sa1855. This data
suggests that the four genes might be co-transcribed from a
common promoter. To examine this possibility, we performed
RT-PCR using the forward primers P1for, P2for, and P3for
specifically binding to sa1857, yeaZ and sa1855, respectively, and a
common reverse primer P4rev specifically binding to gcp. The RT
negative controls using total RNA as a template did not yielded a
PCR product (Fig. 1B, lane 2, 5, 8). In contrast, when cDNA was
used as a template, PCR products of 1.4 kb, 800 bp, and 400 bp
were obtained, corresponding to the expected sizes (Fig. 1B),
indicating that the genes are co-transcribed from at lease one
common promoter.
Staphylococcal Gcp interacts with YeaZ
In E. coli the Gcp homolog, YgjD, interacts with YeaZ [25,26];
in S. aureus, sa1857, yeaZ, sa1855, and gcp genes are localized to the
same operon. These led us to hypothesize that in S. aureus Gcp may
interact with YeaZ, SA1855, and/or SA1857 and function
coordinately. To test this hypothesis, we utilized a yeast two-
hybrid system by fusing Gcp, YeaZ, SA1855 and SA1857
separately with the GAL4 activation domain (GAD) and the
GAL4 DNA binding domain (GBD), respectively. Two different
fusion plasmids were co-transformed into the yeast PJ69-4A
competent cells. The results showed that the negative controls
carrying pGAD-gcp/pGBD, or pGAD/pGBD empty vectors did
not grow in the media lacking His/Leu/Trp, and media lacking
Ade/Leu/Trp (Fig. 2A). In contrast, yeast cells carrying pGAD-
gcp/pGBD-yeaZ grew normally on the above selective media,
indicating a possible binding interaction between Gcp and YeaZ
(Fig. 2A). No other interactions were revealed among these four
proteins (data not shown). In addition, yeast cells carrying either
pGAD-yeaZ/pGBD-gcp or pGAD/pGBD-gcp grew in the above
selective media, suggesting that GBD-Gcp fusion may interact
with the activation domain leading to an auto-activation of the
reporter (data not shown).
To further confirm the interaction between staphylococcal Gcp
and YeaZ, we performed in vitro pull down assays using the
purified His-tagged Gcp and GST-YeaZ fusion proteins. The
GST tag was used to immobilize YeaZ on glutathione Sepharose
resin. Western blot analysis showed that the YeaZ bound resin was
able to retain the refolded Gcp, whereas the control resin alone
could not retain the Gcp (Fig. 2B), indicating that the recombinant
staphylococcal Gcp specifically binds to the recombinant staph-
ylococcal YeaZ.
The overexpression of Gcp in E. coli resulted in the recombinant
protein forming inclusion bodies, thus the recombinant protein
was purified under denaturing conditions, and refolded by a series
of dialysis. Sequence analysis of Gcp revealed four cysteine
residues in the C-terminus, thus it is possible for the purified
recombinant Gcp molecules to form intermolecular disulfide
bonds, which would result in malfunctioning Gcp polymers. To
rule out this possibility, we examined the integrity of unfolded and
refolded recombinant Gcp proteins by SDS-PAGE under non-
reducing condition and did not reveal any oligomers of Gcp (data
not shown).
C-terminal Y317–Y336 segment is crucial for the
staphylococcal Gcp binding to YeaZ
In order to identify which domains of staphylococcal Gcp are
important for the Gcp-YeaZ interaction, we created nine different
truncated Gcp mutants by PCR (Fig. 3A). These truncated Gcp
Figure 1. The co-transcription of the sa1857, sa1856 (yeaZ),
sa1855, and sa1854 (gcp) genes. (A) Schematic representation of
sa1857, sa1856 (yeaZ), sa1855, and sa1854 (gcp) genes in S. aureus. (B)
RT-PCR using different primer pairs. RT (2), total RNA of S. aureus used
as the template; RT (+), cDNA used as the template; positive controls,
the genomic DNA used as the template (lane 1, 4, 7); M, 1 kb DNA
ladder.
doi:10.1371/journal.pone.0020163.g001
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respectively, and the resulting recombinant plasmids were utilized
to conduct Y2H analyses with pGBD-yeaZ. The results showed
that the yeast cells carrying Gcpseg1 mutant (E337–E341
truncated Gcp) and YeaZ grew on both SC-His, -Leu, -Trp and
SC-Ade, Leu, -Trp selective plates. However, the yeast cells
carrying other truncated Gcp fusions and YeaZ did not grow on
these selective plates (Fig. 3B).
Alanine scanning mutagenesis has been successfully and
extensively utilized in the determination of enzymatic and
functional residues of proteins [30–32]. Substitution of alanine
removes all side chain atoms beyond b carbon and yet maintains
the main chain structure [30]. To further identify which residue(s)
is required for Gcp binding to YeaZ, we utilized this approach to
substitute potential hot residues of the C-terminal Y317–Y336
segment with alanine. The critical Y317–Y336 segment was
divided into three regions, including Y317-F322, D324-N329, and
S332-Y336 regions as shown in Fig. 4A. Five to six amino acids in
these regions were replaced by alanine stretches, respectively. The
mutated gcp fragments were fused with the activation domain of
pGAD, which was used for the Y2H assays. We found that the
yeast cells carrying with Gcp317-322A and YeaZ did not grow on
any SC dropout selective medium (Fig. 4B); the yeast cells carrying
Gcp324-329A or Gcp332-336A, and YeaZ appeared to have a
dramatic growth defect on the selective medium (Fig. 4B). Taken
together, the above data indicate the importance of the C-terminal
region of Gcp for proper interaction with YeaZ, specifically the
region of Y317-F322 and to a lesser extent the regions of D324-
N329 and S332-Y336.
Staphylococcal Gcp alanine mutants cannot complement
wild type Gcp for bacterial growth
We have previously demonstrated that Gcp is essential for S.
aureus growth [5,6], but the molecular mechanisms of Gcp’s
essentiality remain elusive. The discovery that Gcp interacts with
YeaZ led us to hypothesize that their interaction is important for
Gcp’s essentiality. In order to examine this hypothesis, we first
created the Gcp complementary system (Fig. 5A). Then, we
examined the complementary effect of gcp expression in trans by
measuring the bacterial growth during the depletion of endoge-
nous Gcp. The results showed that the growth of the staphylo-
coccal Gcp complementary strain was IPTG-independent, indi-
cating the gcp expression in trans complements the depletion of
endogenous Gcp (Fig. 5B), whereas the growth of the parental
control was IPTG-dependent (Fig. 5C). These data further
demonstrated the requirement of Gcp for bacterial viability in
culture and the feasibility of the Gcp complementary system.
Next, we determined whether the identified segment and
regions that are crucial for Gcp interaction with YeaZ are also
required for growth by examining the complementary effect of the
mutated Gcp genes. The results showed that the growth of the
Pspac-regulated gcp expression strain carrying complementary
Gcpseg1 was independent of IPTG (Fig. 5D), indicating that the
expression of Gcpseg1 in trans can complement Gcp and the C-
terminal region E337–E341 is dispensable for Gcp’s essentiality. In
contrast, the growth of the Pspac-regulated gcp expression strain
carrying complementary Gcpseg2 was still dependent on IPTG
(Fig. 5E). To determine which domain is critical for growth, we
examined the complementary effect of Gcp317-322A, Gcp324-
329A and Gcp332-336A, and found that the Pspac-regulated gcp
expression strains carrying Gcp317-322A (Fig. 5F), Gcp324-329A
(Fig. 5G), or Gcp332-336A (Fig. 5H) mutant exhibited IPTG
dependent growth, indicating that these mutated Gcp are unable
to complement the depletion of endogenous Gcp. These data
suggest that the three domains, Y317-F322, D324-N329, and
S332-Y336, are likely critical for Gcp’s essentiality.
No O-sialoglycoprotein endopeptidase activity was
detected for the recombinant staphylococcal Gcp and
YeaZ proteins
To determine whether the novel essential proteins Gcp and
YeaZ possess an O-sialoglycoprotein endopeptidase activity, the
purified recombinant Gcp and YeaZ were utilized to treat O-
sialoglycoprotein, glycophorin A, according to the manufacturer’s
instruction. The degradation of glycophorin A protein was
detected by SDS-PAGE and western blot using a monoclonal
Figure 2. The determination of Gcp binding to YeaZ. (A) Yeast two hybrid analysis of interaction between Gcp and YeaZ on histidine, leucine,
and tryptophan drop out synthetic complete (SC-His, -Leu, -Trp) plates with 3-amino-1,2,4,-triazole (3-AT) and SC plates lacking adenine, leucine, and
tryptophan (SC-Ade, -Leu, -Trp). Gcp was fused with the activation domain and YeaZ was fused to binding domain. The minus signs indicate empty
vector controls. (B) In vitro immunoprecipitation analysis of interaction between Gcp and YeaZ. His-tagged Gcp and GST-tagged YeaZ were purified
from E. coli. Gcp and YeaZ were incubated with Glutathione Sepharose 4B beads together or separately. Western blotting was carried out with rabbit-
anti-Gcp serum to detect Gcp. Lane 1: purified Gcp protein was loaded as a positive control.
doi:10.1371/journal.pone.0020163.g002
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glycophorin A was detected after treatment with Gcp of M.
haemolytica A1 (Fig. 6A), whereas no degradation of glycophorin A
was detected after treatment with recombinant Gcp, YeaZ, or the
combination of Gcp and YeaZ (Fig. 6A). In addition, we revealed
that the purified recombinant staphylococcal YeaZ did not cleave
recombinant Gcp of S. aureus under the conditions in the presence
or absence of Mg
2+,M n
2+,C a
2+,Z n
2+ (Fig. 6B).
Discussion
In the present study, we employed genetic and biochemical
approaches and demonstrated that in the gcp operon of S. aureus,
the essential Gcp protein interacts with another essential protein
YeaZ. More importantly, we identified key domains of Gcp that
are not only required for Gcp binding to YeaZ, but also play
important roles in Gcp’s essentiality for bacterial growth. Our
results suggest that the interaction of Gcp and YeaZ may
contribute to the essentiality of Gcp. In addition, our results
showed that there was neither O-sialoglycoprotein endopeptidase
activity nor Gcp specific protease activity detected for the purified
recombinant staphylococcal Gcp and/or YeaZ, suggesting that the
staphylococcal Gcp and YeaZ may function differently compared
to their homologs in M. hemolytica and E. coli, respectively. These
findings may provide new insights into the molecular mechanisms
and biological function of the essential protein, Gcp.
The identification of the staphylococcal Gcp-YeaZ interaction is
consistent with the previous report that the Gcp homolog in E. coli,
YgjD, binds to YeaZ the homolog of SA1856 [25,26]. However, in
E. coli another essential protein, YjeE, also interacts with YeaZ,
suggesting that YjeE may function as a regulator to modulate
YeaZ-YgjD interaction, and that the YjeE-YeaZ-YgjD network
may be involved in an essential cellular process [26]. In contrast, in
S. aureus there is no report indicating that the homolog of YjeE,
SA1857, is indispensable for bacterial viability [10]. We are in the
process of examining the requirement of SA1857 and SA1855 for
the growth of S. aureus. Furthermore, in our Y2H studies we found
no evidence that SA1857 and SA1855 interacts with either Gcp or
YeaZ. Although the staphylococcal YeaZ and Gcp proteins have
approximately 26% and 42% identity compared to E. coli YeaZ
and YgjD sequences, respectively, our studies indicate that Gcp
and YeaZ likely function differently or interact with different
partner proteins compared to their homologs in E. coli.W e
observed that in Y2H assays the growth of yeast cells on SC-His
plates seems to be faster than on SC-Ade plates. This is likely due
to the stringent growth difference between SC-Ade and SC-His
selective medium [33]. Although we unveiled that the mutation of
Y317-F322 region eliminated the ability of Gcp to bind YeaZ, and
the mutations of D324-N329 and S332-Y336 regions alleviated
the capacity of Gcp to bind YeaZ, the attenuated binding ability
may be attributable to the altered tertiary conformation of Gcp.
To determine the potential impact of topology for mutated Gcp
proteins is beyond scope of the present study. However, we are
currently working to further characterize and define the
interaction of Gcp and YeaZ and identify the critical residue(s)
for Gcp to bind YeaZ and vice versa.
In both yeast and archaea, Kae1p (Gcp homolog) directly
interacts with a Bud32p kinase, inhibiting the kinase activity,
which is required both for transcription and the telomere
homeostatic function of the endopeptidase-like kinase chromatin-
associated (EKC)/kinase, endopeptidase, and other peptidases of
small size (KEOPS) in yeast cells [21,23,24]. In eukaryotes, the
Gcp homolog is Qri7 in yeast and OSGEPL1 (O-sialoglycoprotein
endopeptidase) in worm and human. Qri7 and OSGEPL1 anchor
to the mitochondrial inner membrane and are essential for the
maintenance of mitochondrial genome [18,34]. Qri7 is able to
complement the depletion of E. coli YgjD (homolog of Gcp),
whereas Kae1 fails to do so, suggesting the functional similarity
between Qri7 and YgjD [34]. Although bacteria lack a Bud32
homolog, YeaZ may substitute for Bud32 to form a functional
complex with Gcp. Our complementation experiments established
that the mutations of Gcp that disrupt the Gcp-YeaZ interaction
could not complement the depletion of endogenous Gcp. We also
observed that the deletion of the C-terminal residues, E337–E341,
slightly impaired the ability of Gcp to interact with YeaZ (Fig. 3B);
and consequently, this truncated Gcp (Gcpseg1) delayed its
complementary effect on bacterial growth (longer lag-phase of
growth). These data suggest that the staphylococcal Gcp-YeaZ
interaction may play an important role in Gcp’s essentiality; thus
the interruption of Gcp-YeaZ interaction may be utilized as a
novel mode of action for developing new classes antibacterial
agents, partially against MRSA or VRSA caused infections. It is
known that bacterial autolysis is important for bacterial cell
division and growth. Previously, we have demonstrated that the
staphylococcal Gcp is a critical modulator of bacterial autolysis
[6]; however, the mechanism of regulation of autolysis by Gcp
remains to be determined; it is necessary to explore the potential
role of the Gcp-YeaZ interaction in the process of autolysis.
Figure 3. Diagrams represent different deletion mutations of
Gcp (A); and interactions between S. aureus Gcp and YeaZ
detected by yeast two-hybrid analyses (B). Yeast cells containing
the indicated plasmids were serially diluted, and 5 ml of diluted cells was
spotted on the plate with media lacking histidine, leucine, and
tryptophan; or lacking adenine, leucine, and tryptophan to score for
interactions after incubation at 30uC.
doi:10.1371/journal.pone.0020163.g003
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not appear to have an O-sialoglycoprotein endopeptidase activity
against glycophorin A. We also employed an alternative
approach to examine the potential glycoprotease activity by
measuring cell associated ligand, PSGL1 (P-selectin glycoprotein
ligand 1), using FACS. Neither the purified recombinant
staphylococcal Gcp, YeaZ, nor the concentrated supernatants
of S. aureus culture appeared to have the glycoprotease activity
(data not shown). Our results are in agreement with previous
reports that YgjD (homolog of Gcp in E. coli)a n dK a e 1( h o m o l o g
of Gcp in Pyrococcus abyssi) do not exhibit any endopeptidase
activity [20,26]. In addition, E. coli YeaZ is able to specifically
cleave YgjD (the homolog of Gcp), whereas consistent with S.
typhimurium YeaZ [28] our purified soluble recombinant staphy-
lococcal YeaZ did not exhibit such a protease activity. The lack of
protease activity of purified recombinant Gcp and YeaZ may
result from potential modifications during expression and
purification process. However, it is likely that the Gcp and YeaZ
homologs may have different biological functions among different
species, because sequence alignment analysis revealed that the
staphylococcal Gcp does not possess any E. coli YeaZ cleavage
sites, including K171- L172 and F195-V196 residues that were
identified in YgjD [26]. In addition, we cannot exclude the
possibility that the staphylococcal Gcp and YeaZ proteins may
possess a specific proteolytic activity against a substrate in a
process that is critical for the viability of S. aureus.
In conclusion, we demonstrated within the four novel proteins
encoded by the gcp operon, the essential Gcp interacts with
another essential protein YeaZ of S. aureus. Moreover, we
identified the C-terminal Y317-F322, D324-N329, and S332-
Y336 regions to be important for Gcp to bind YeaZ, as well as for
Gcp’s essentiality, whereas the C-terminal E337–E344 region is
dispensable for the staphylococcal Gcp-YeaZ interaction and
Gcp’s essentiality. These data suggest that the interaction of Gcp
and YeaZ may at least partially contribute to the essentiality of
Gcp for S. aureus growth. Our findings provide new insights into
the potential mechanisms and biological function of the novel
essential protein, Gcp, as well as potential novel targets for the
development of new classes antibacterial agents.
Materials and Methods
Bacterial strain and culture medium
The bacterial strains and plasmids used in the study are listed in
Table 1. E. coli strain, DH10B, was used as a host for recombinant
plasmid construction and amplification. Luria-Bertani (LB) liquid
medium and LB-agar plates were used for the growth and
maintenance of E. coli. The E. coli strain BL21(DE3) was used as a
host strain for the expression of recombinant Gcp and YeaZ.
Ampicillin was used at 100 mg/ml in LB media for the selection of
E. coli carrying the plasmid pGEX4T-1, pMY1107, or Yeast two-
hybrid (Y2H) vectors pGAD-C1 and pGBD-C1. Kanamycin was
used at 50 mg/ml in LB media for the selection of E. coli carrying
plasmid pET24b. A Saccharomyces cerevisiae strain, PJ69-4A, was
used in Y2H studies [33]. The PJ69-4A strain has three reporter
genes for a positive Y2H interaction: HIS3 driven by GAL1
promoter, ADE2 by the GAL2 promoter, and lacZ by the GAL7
promoter. YEPD (1% yeast extract, 2% peptone, 2% dextrose,
pH 6.0) and synthetic complete (SC) liquid medium and plates
were used for S. cerevisiae growth. Where indicated, certain
components were dropped out from the SC media. A Pspac-
regulated gcp mutant of S. aureus was constructed as previously
described [5], which was used as a host cell for complementation
experiments. S. aureus was grown in Tryptic Soy Broth (TSB)
containing erythromycin (5 mg/ml) and different concentrations of
isopropyl b-D-1-thiogalactopyranoside (IPTG) at 37uC with
shaking.
RNA purification and RT-PCR analysis
Overnight cultures of S. aureus were used at 1% inoculum in
TSB medium and grown to the medium-exponential phase of
growth. Cells were harvested by centrifugation, and the total RNA
Figure 4. Diagrams represent different alanine substitutions of amino acids in Gcp (A); and interactions between S. aureus Gcp and
YeaZ detected by yeast two-hybrid analyses (B). Yeast cells containing the indicated plasmids were serially diluted, and 5 ml of diluted cells was
spotted on the plate with media lacking histidine, leucine, and tryptophan (SC-His, -Leu, -Trp); or lacking adenine, leucine, and tryptophan (SC-Ade, -
Leu, -Trp) to score for interactions after incubation at 30uC.
doi:10.1371/journal.pone.0020163.g004
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Contaminating DNA was removed with a TURBO DNA-free
Kit (Ambion), and the RNA yield was determined spectrophoto-
metrically at 260 nm. The cDNA was synthesized by employing
RNA as a template using the Promega-reverse transcription kit.
Co-transcription of gcp operon was determined by RT-PCR using
primers listed in Table 2.
Examination of protein interactions using the Y2H
system
To examine possible protein-protein interaction, we employed a
yeast two-hybrid (Y2H) technology as described [33,35]. The
staphylococcal gcp, sa1855, yeaZ and sa1857 genes were amplified
by PCR using the primers listed in Table 1. PCR products were
purified, cloned into EcoRI and BglII sites of pGAD-C1 two-hybrid
vector containing GAL4 transcription activation domain (GA-
L4AD) and BamHI and SalI sites of pGBD-C1 vector containing
GAL4 DNA-binding domain (GAL4BD), respectively. The yeast
strain PJ69-4A was co-transformed with the two fusion plasmids
using the high efficiency LiAc-PEG method [35]. The yeast
transformants were grown on SC drop-out plates lacking leucine
and tryptophan at 30uC. The examination was performed either
by streak plates or by spotting plates with serial dilutions of
suspension on SC plates lacking leucine, tryptophan and histidine
with 2 mM 3-amino-1,2,4,-triazole (3-AT) (SC-His, -Leu, -Trp)
and SC plates lacking leucine, tryptophan and adenine (SC-Ade, -
Leu, -Trp). For the spots assays, yeast cells in exponential growth
were harvested and resuspended at 4610
6 cells per milliliter. A
volume of 5 ml of this cell suspension and its 5 fold serial dilutions
were spotted on plates with decreasing concentrations from left to
right. Growth on plates was examined daily and documented after
4 days of incubation.
Cloning, expression and purification of recombinant Gcp-
His tag fusion protein and GST-YeaZ fusion protiens
The staphylococcal gcp and yeaZ genes were obtained by PCR
using the primers listed in Table 2 and cloned into NdeI and XhoI
sites of pET24b and BamHI and SalI sites of pGEX4T-1,
respectively. The recombinant plasmids were transformed into
E. coli strain BL21 (DE3), respectively. An approximately 500 ml
culture of each strain in LB medium was incubated aerobically at
37uC to an optical density (OD) at 600 nm of 0.6. The
recombinant protein expression was subsequently induced by the
addition of 1 mM IPTG. After 5 h of incubation at 37uC, cells
were harvested. For the purification of Gcp-His fusion proteins,
the cell pellet was collected and resuspended in the binding buffer
(300 mM NaCl, 50 mM NaH2PO4, 8 M urea, 10 mM imidazole,
pH 8.0) with the addition of 1 mg/ml lysozyme and 1 mM PMSF
at room temperature for 1 h. The cells were lysed by sonication on
ice; after centrifugation at 25,000 g for 20 min at 4uC, the
supernatant was collected and applied onto Ni-NTA resin
(Qiagen) under denaturing condition according to the manufac-
turer’s instruction. The purified recombinant Gcp proteins were
refolded by dialysis using a series of dialysis buffers (300 mM
NaCl, 50 mM NaH2PO4, 10% glycerol with 4 M, 2 M, 1 M, 0 M
urea, final buffer 150 mM NaCl, 20 mM NaH2PO4, PH 7.3). For
the purification of GST-YeaZ proteins, the cell pellet was
resuspended in the binding buffer (150 mM NaCl, 20 mM
NaH2PO4, pH 7.3) containing 1 mg/ml lysozyme and 1 mM
PMSF at room temperature for 1 h. The cells were lysed by
sonication on ice; after centrifugation at 25,000 g for 20 min at
4uC, the supernatant was collected and mixed with Glutathione
Sepharose 4B beads (GE Healthcare) according to the manufac-
turer’s instructions. The purified recombinant proteins were
confirmed by SDS-polyacrylamide gel electrophoresis (PAGE)
followed by Coomassie bright blue staining; the protein concen-
tration was measured using the BCA
TM Protein Assay kit (Thermo
Scientific).
In vitro pull down assay
Purified GST-YeaZ fusion protein was mixed with Glutathi-
one Sepharose 4B resin at room temperature and allowed to
bind for 30 min. A total of 15 ml of resin bound GST-YeaZ
Figure 6. SDS-PAGE and Western blot analysis of Gcp and
YeaZ’s protease activity. (A) Western blot results showing hydrolysis
of Glycophorin A. GPA2 and GPA represent dimer and monomer of
glycophorin A. 10 mg glycophorin A was incubated with PBS (lane 1),
5 mg O-sialoglycoprotein endopeptidase (Gcp) of P. haemolytica
(Cedarlane Laboratories, lane 2), 5 mg Gcp (lane 3), 25 mg Gcp (lane
4), 50 mg Gcp (lane 5), 33 mg YeaZ (lane 6) and 5 mg Gcp and 3.3 mg
YeaZ (lane 7). (B) SDS-PAGE analysis of the impact of the recombinant
staphylococcal YeaZ on Gcp.
doi:10.1371/journal.pone.0020163.g006
Figure 5. The impact of the expression of wild type or mutated Gcp in trans on the growth of the Pspac-regulated gcp expression
strain. (A) Construction of Gcp complementation system using the Pspac-regulated gcp expression strain and Western blot analysis of gcp expression
in trans. Lane 1, purified recombinant Gcp; lane 2, negative control (JRN0210); lane 3, Gcp complementary strain (JNR0110). Without an inducer, ATc,
Gcp is constitutively expressed due to the leakage of Pxyl/tetO promoter. (B–H) Growth curves of Gcp complementary strains. The Pspac-regulated
gcp expression S. aureus strain carrying the staphylococcal wild-type gcp complementary plasmid, pXL108 was used as positive control (B); carrying
parental plasmid, pMY1107, as a negative control (C); carrying the gcpseg1 complementary plasmid, pLT109 (D); carrying the gcpseg2 complementary
plasmid, pLT209 (E); carrying the gcp1-1 complementary plasmid, pLT309 (F); carrying the gcp1-2 complementary plasmid, pLT409 (G); carrying the
gcp1-3 complementary plasmid, pLT509 (H). The above strains were incubated overnight in TSB in the presence of appropriate antibiotics and
0.2 mM IPTG. Bacteria were diluted and incubated in fresh TSB containing appropriate antibiotics and different concentration of IPTG at 37uC with
shaking. The cell growth was monitored by measuring OD600 nm every 15 min for 18 h with 1 min mixing before each reading.
doi:10.1371/journal.pone.0020163.g005
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Gcp-His tag protein for 2 h at room temperature, washed 6
times with phosphate buffer solution using the equivalent
volume of 100 times the bead bed volume, and eluted by
mixing with 26 the bead bed volume of elution buffer
containing 10 mM reduced glutathione. The elution fraction
was subjected to SDS-PAGE and standard western blotting
using rabbit anti-Gcp serum.
Table 1. Strains and plasmids used in this study.
Strain or plasmid Description Reference
Strains
RN4220 Laboratory strain; rsbU
2 [39]
WCUH29 Clinical human isolate; rsbU
+ [40]
JRN0105 RN4220::Pspac-gcp, spac promoter regulated gcp expression mutant [5]
JRN0110 JRN0105 with plasmid pXL108 This study
JRN0210 JRN0105 with plasmid pMY1107 This study
JRN0310 JRN0105 with plasmid pLT109 This study
JRN0410 JRN0105 with plasmid pLT209 This study
JRN0510 JRN0105 with plasmid pLT309 This study
JRN0610 JRN0105 with plasmid pLT409 This study
JRN0710 JRN0105 with plasmid pLT509 This study
PJ69-4A MATa trp1-901 leu2-3, 112 ura3-52 his3-200 gal4Dgal80DLYS2::GAL1-HIS3 GAL2-ADE2
met2::GAL7-lacZ
[33]
Plasmids
pGEX4T-1 Overexpression vector, can be used to add GST tag to the N terminal of protein of interestGE Healthcare
pET-24b Overexpression vector, can be used to add His tag to the N or C terminal of protein of
interest
Novagen
pGAD-C1/pGBD-C1 Y2H vector carrying GAL4 transcription activation/DNA binding domain [33]
pGAD/gcp pGAD-C1 carrying gcp This study
pGAD/gcpseg1 pGAD-C1 carrying gcpseg1 mutant This study
pGAD/gcpseg2 pGAD-C1 carrying gcpseg2 mutant This study
pGAD/gcpseg3 pGAD-C1 carrying gcpseg3 mutant This study
pGAD/gcpseg4 pGAD-C1 carrying gcpseg4 mutant This study
pGAD/gcpseg5 pGAD-C1 carrying gcpseg5 mutant This study
pGAD/gcpseg6 pGAD-C1 carrying gcpseg6 mutant This study
pGAD/gcpseg7 pGAD-C1 carrying gcpseg7 mutant This study
pGAD/gcpseg8 pGAD-C1 carrying gcpseg8 mutant This study
pGAD/gcpseg9 pGAD-C1 carrying gcpseg9 mutant This study
pGAD/gcp1-1 pGAD-C1 carrying gcp1-1 mutant This study
pGAD/gcp1-2 pGAD-C1 carrying gcp1-2 mutant This study
pGAD/gcp1-3 pGAD-C1 carrying gcp1-3 mutant This study
pGAD/sa1855 pGAD-C1 carrying sa1855 This study
pGAD/yeaZ pGAD-C1 carrying yeaZ This study
pGAD/sa1857 pGAD-C1 carrying sa1857 This study
pGBD/gcp pGBD-C1 carrying gcp This study
pGBD/sa1855 pGBD-C1 carrying sa1855 This study
pGBD/yeaZ pGBD-C1 carrying yeaZ This study
pGBD/sa1857 pGBD-C1 carrying sa1857 This study
pMY1107 pFF40 inserted with TetR regulation region This study
pXL108 pMY1107 carrying gcp This study
pLT109 pMY1107 carrying gcpseg1 mutant This study
pLT209 pMY1107 carrying gcpseg2 mutant This study
pLT309 pMY1107 carrying gcp1-1 mutant This study
pLT409 pMY1107 carrying gcp1-2 mutant This study
pLT509 pMY1107 carrying gcp1-3 mutant This study
doi:10.1371/journal.pone.0020163.t001
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To identify the domains of Gcp important for binding to YeaZ,
we performed alanine scanning mutagenesis assays. Five to six
amino acids of alanine per stretch replaced the native amino acids
and were generated by PCR using the primers listed in Table 2 as
previously described [36]. In brief, six pairs of primers were
designed, including Gcpfor1 with Gcp1-1revSacII, Gcp1-2revSa-
cII and Gcp1-3revSacII, and GcprevAscI with Gcp1-1forSacII,
Gcp1-2forSacII and Gcp1-3forSacII (Table 2). Three different 59
end segments and 39 end segments of gcp were amplified by PCR,
ligated to SacII site, and reformed mutated gcp1-1, gcp1-2, and gcp1-
3, respectively. These mutated genes encode three different C-
terminal alanine stretch mutants, Gcp317-322A, Gcp324-329A,
and Gcp332-336A, accordingly.
Construction of complementary plasmid and
characterization of bacteria growth
In order to examine whether the expression of wild type or the
constructed alanine mutants of Gcp in trans are able to
complement the depletion of endogenous Gcp, we created a
complementary plasmid using a shuttle vector, pFF40, which
expresses the lacI gene [37]. A TetR regulatory cassette, obtained
by PCR, was inserted into the SacII site of pFF40 and the new
plasmid was designated as pMY1107. The wild type and alanine
mutant gcp genes were obtained by PCR using the primers listed in
Table 2 and cloned into the PmeI and AscI sites of pMY1107,
resulting in plasmids pXL108, pLT109, pLT209, pLT309,
pLT409, and pLT509. The recombinant plasmids were electro-
phorated into the Pspac-regulated gcp S. aureus mutant [5]. The
growth curves of transformed S. arueus were obtained using an
automated microtiter plate format on SpectrMaxPlus384 spectro-
photometer (Molecular Devices). S. aureus strains were incubated in
TSB with appropriate antibiotics and different concentrations of
IPTG (0, 5, 20, 50 and 100 mM) at 37uC. Cell growth was
monitored by measuring OD600 nm every 15 min with 1 min
mixing before each reading.
Enzymatic activity analysis
To determine whether the staphylococcal Gcp and YeaZ
possess any O-sialoglycoprotein endopeptidase activity or protease
activity, purified recombinant Gcp and YeaZ proteins were
utilized to treat O-sialoglycoprotein glycophorin A (Sigma) as
described [38]. The degradation of glycophorin A protein was
detected by SDS-PAGE and western blotting using a monoclonal
antibody against glycophorin A. To examine the effect of different
ions, including magnesium, calcium, and zinc on the potential
enzymatic activity, the purified recombinant Gcp and/or YeaZ
was incubated with glycophorin A in individual reaction buffers
containing different concentrations of Mg
2+,M n
2+,C a
2+,o rZ n
2+
at 37uC for 3 h.
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